Exchange Traded Concepts, LLC Seagen Inc. Transaction History

Exchange Traded Concepts, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$191.51 - $216.16 $2.56 Million - $2.89 Million	-13,390 Reduced 96.25%	521 $110,000
Q2 2023 Jul 20, 2023	BUY	$187.64 - $206.25 $2.61 Million - $2.87 Million	13,897 Added 99264.29%	13,911 $2.68 Million
Q1 2023 Apr 12, 2023	BUY	$127.59 - $203.08 $1,786 - $2,843	14 New	14 $2,000
Q3 2022 Oct 07, 2022	BUY	$135.27 - $180.11 $2,705 - $3,602	20 New	20 $3,000
Q1 2022 Apr 26, 2022	SELL	$119.61 - $157.85 $368,039 - $485,704	-3,077 Closed	0 $0

Q4 2021 Jan 13, 2022	SELL	$142.57 - $190.86 $287,563 - $384,964	-2,017 Reduced 39.6%	3,077 $476,000
Q3 2021 Oct 18, 2021	BUY	$142.45 - $169.82 $433,760 - $517,101	3,045 Added 148.61%	5,094 $865,000
Q2 2021 Jul 30, 2021	BUY	$135.08 - $161.1 $9,995 - $11,921	74 Added 3.75%	2,049 $323,000
Q1 2021 Apr 20, 2021	SELL	$137.51 - $190.8 $492,560 - $683,445	-3,582 Reduced 64.46%	1,975 $274,000
Q4 2020 Jan 19, 2021	BUY	$164.63 - $211.93 $914,848 - $1.18 Million	5,557 New	5,557 $973,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.